Release Date: 28/01/22 14:25 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 10.81MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%